经斑贴试验证实为非那唑吡啶(吡啶)迟发性药疹。

IF 1.6 Q3 ALLERGY

Asia Pacific Allergy Pub Date : 2022-01-25 eCollection Date: 2022-01-01 DOI:10.5415/apallergy.2022.12.e10

Winnie W Y Yeung, Christina S M Wong, Wai-Yan Leung, Philip H Li

引用次数: 0

摘要

青霉素的迟发性超敏反应是常见的，但从未报道过铂。本病例描述了一个患者在使用augmentin和pydium后出现迟发性超敏反应。皮肤贴片试验，很意外，证实了吡啶迟发性超敏反应。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Delayed-type drug eruption to phenazopyridine (pyridium) confirmed with patch testing.

查看原文本刊更多论文

Delayed-type drug eruption to phenazopyridine (pyridium) confirmed with patch testing.

Delayed hypersensitivity reaction of penicillin is commonly seen, but never reported in pyridium. This case illustrates a patient with delayed hypersensitivity reaction after the use of augmentin and pyridium. Skin patch test, surprisingly, confirmed pyridium delayed hypersensitivity.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Asia Pacific Allergy ALLERGY-

CiteScore

2.50

自引率

5.90%

发文量

期刊介绍： Asia Pacific Allergy (AP Allergy) is the official journal of the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI). Although the primary aim of the journal is to promote communication between Asia Pacific scientists who are interested in allergy, asthma, and clinical immunology including immunodeficiency, the journal is intended to be available worldwide. To enable scientists and clinicians from emerging societies appreciate the scope and intent of the journal, early issues will contain more educational review material. For better communication and understanding, it will include rational concepts related to the diagnosis and management of asthma and other immunological conditions. Over time, the journal will increase the number of original research papers to become the foremost citation journal for allergy and clinical immunology information of the Asia Pacific in the future.